Back to FEDERATED HERMES, INC. FEDERATED HERMES, INC.

ARQTARQT
Showing 8 of 15 quarters

Position history for FEDERATED HERMES, INC.FEDERATED HERMES, INC.'s holdings in ARCUTIS BIOTHERAPEUTICS INC

FEDERATED HERMES, INC. holds 1.1M shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), worth $29.5M as of 2026-Q2. The position was increased (+4.4% shares). ARQT represents 0.0% of FEDERATED HERMES, INC.'s portfolio.

Current Value

$29.5M

Current Shares

1.1M

Total Value Change

+$24.8M

Total Shares Change

+622,798

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+4.4%
$29.5M0.0%$26.22
30
2026-Q1
Increased
1.1M
+20.8%
$25.4M0.0%$23.56
34
2025-Q4
Increased
891,767
+17.4%
$25.9M0.0%$29.04
33
2025-Q3
Increased
759,573
+3.0%
$14.3M0.0%$18.85
29
2025-Q2
Decreased
737,369
-0.0%
$10.3M0.0%$14.02
0
2025-Q1
Increased
737,555
+49.6%
$11.5M0.0%$15.64
38
2024-Q4
Decreased
492,922
-1.8%
$6.9M0.0%$13.93
0
2024-Q3
Increased
501,831
+43.3%
$4.7M0.0%$9.30
36

Other major holders of ARQT: BlackRock, Inc., JENNISON ASSOCIATES LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used